Who invested in Chordia Therapeutics?
Chordia Therapeutics's investors include Mitsubishi UFJ Capital, SMBC Venture Capital, Sumitomo Mitsui Banking Corporation and Kyoto University Innovation Capital Co., Ltd.
Who invested in Chordia Therapeutics
Funding summaryUpdated 26 Oct 2026
$27Mraised across 1 round since 2019, from 1 source
- Latest round
- Series B, $27MApr 2019
- Investors
- 4
The rounds
- Apr 2019
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Chordia Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Chordia Therapeutics
How much has Chordia Therapeutics raised?
Chordia Therapeutics has raised $27M across 1 round since 2019.
When did Chordia Therapeutics last raise?
Chordia Therapeutics's most recent round was a Series B of $27M in Apr 2019.
What was Chordia Therapeutics's biggest round?
Its most recent round, $27M in Apr 2019, is also its largest on record.
Who backed Chordia Therapeutics first?
Chordia Therapeutics's first round on record, in Apr 2019, was backed by Mitsubishi UFJ Capital, SMBC Venture Capital and Sumitomo Mitsui Banking Corporation and 1 others.
What stage is Chordia Therapeutics at?
Chordia Therapeutics's latest named round is a Series B, in Apr 2019.
Companies like Chordia Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.